ERBB2 and metastatic neoplasm: In patients with luminal-like phenotype at diagnosis, the most frequently mutated gene during metastatic disease was PIK3CA (39.8%); in those with HER2+ phenotype, ERBB2 was the most frequently altered gene (30%) (Figure 1a,b).